NCT00129311View on ClinicalTrials.gov

Usefulness of Selegiline as an Aid to Quit Smoking - 1

PHASE2CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Tobacco Use Cessation

Interventions

DRUG

Selegiline

5 mg capsules taken by mouth. Participants take 5 mg once a day for the first week of the study, then increase the dose to 5 mg twice a day for 6 weeks, then take 5 mg once a day during the last week of the study. Participants receiving the placebo pill take 1 pill per day for the first week of the study and 1 pill twice a day for the other weeks.

DRUG

Placebo

Trial Locations (1)

06511

PRISM, New Haven

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00129311 - Usefulness of Selegiline as an Aid to Quit Smoking - 1 | Biotech Hunter | Biotech Hunter